We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Draft Guidance Offers Recommendations for Antiviral Drug Development
FDA Draft Guidance Offers Recommendations for Antiviral Drug Development
May 24, 2005
Drugmakers should conduct nonclinical studies of antiviral drug candidates before initiating Phase I clinical trials, according to an FDA draft guidance.